v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2025
Jul. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss, including amounts attributable to noncontrolling interest $ (46,254) $ (43,239)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Stock-based compensation expense 110,111 91,221
Change in fair value of acquisition related contingent consideration 0 3,750
Charitable donation of common stock 3,526 5,914
Amortization of intangible assets 4,035 3,420
Depreciation expense 1,315 1,681
Amortization of deferred contract acquisition costs 27,269 22,946
Net amortization of premiums or discounts on short-term investments (5,605) (9,141)
Unrealized foreign exchange loss (gain), net 10,970 (268)
Other non-cash expense, net 400 301
Changes in assets and liabilities:    
Accounts receivable 69,787 1,225
Prepaid expenses and other current assets 2,746 13,344
Deferred contract acquisition costs (20,430) (20,955)
Other non-current assets 181 (497)
Accounts payable 3,114 1,350
Accrued expenses and other current liabilities (4,278) (21,070)
Accrued compensation and benefits (11,063) (6,902)
Deferred revenue 9,489 14,838
Other non-current liabilities 358 (8,083)
Net cash provided by operating activities 155,671 49,835
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of short-term investments (483,898) (263,258)
Proceeds from maturities of short-term investments 347,886 376,099
Proceeds from sales of short-term investments 1,367 0
Purchases of property and equipment (3,816) (1,551)
Payments for business combination, net of cash acquired 0 (20,210)
Payments for asset acquisition 0 (7,314)
Other investing activities 0 457
Net cash provided by (used in) investing activities (138,461) 84,223
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases 7,275 10,073
Issuance of common stock under employee stock purchase plan 8,404 7,932
Net cash provided by financing activities 15,679 18,005
Impact of foreign exchange on cash and cash equivalents 833 (1,443)
Net increase in cash and cash equivalents 33,722 150,620
Cash and cash equivalents at beginning of period 227,649 287,996
Cash and cash equivalents at end of period 261,371 438,616
Supplemental disclosure of cash flow information:    
Cash paid (refunds) for income taxes (1,676) 1,803
Supplemental disclosure of non-cash investing and financing activities:    
Unpaid property and equipment in accounts payable and accrued expenses 977 87
Unpaid direct transaction costs related to the asset acquisition in accrued expenses $ 0 $ 346